Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Plast Reconstr Surg ; 140(6): 1235-1239, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29176416

RESUMO

BACKGROUND: Of U.S. craniofacial and neurosurgeons, 94 percent routinely admit patients to the intensive care unit following cranial vault remodeling for correction of sagittal synostosis. This study aims to examine the outcomes and cost of direct ward admission following primary cranial vault remodeling for sagittal synostosis. METHODS: An institutional review board-approved retrospective review was undertaken of the records of all patients who underwent primary cranial vault remodeling for isolated sagittal craniosynostosis from 2009 to 2015 at a single pediatric hospital. Patient demographics, perioperative course, and outcomes were recorded. RESULTS: One hundred ten patients met inclusion criteria with absence of other major medical problems. Average age at operation was 6.7 months, with a mean follow-up of 19.8 months. Ninety-eight patients (89 percent) were admitted to a general ward for postoperative care, whereas the remaining 12 (11 percent) were admitted to the intensive care unit for preoperative or perioperative concerns. Among ward-admitted patients, there were four (3.6 percent) minor complications; however, there were no major adverse events, with none necessitating intensive care unit transfers from the ward and no mortalities. Average hospital stay was 3.7 days. The institution's financial difference in cost of intensive care unit stay versus ward bed was $5520 on average per bed per day. Omitting just one intensive care unit postoperative day stay for this patient cohort would reduce projected health care costs by a total of $540,960 for the study period. CONCLUSION: Despite the common practice of postoperative admission to the intensive care unit following cranial vault remodeling for sagittal craniosynostosis, the authors suggest that postoperative care be considered on an individual basis, with only a small percentage requiring a higher level of care. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.


Assuntos
Craniossinostoses/cirurgia , Craniotomia/métodos , Cuidados Críticos/estatística & dados numéricos , Cuidados Pós-Operatórios/estatística & dados numéricos , Perda Sanguínea Cirúrgica , Transfusão de Sangue/estatística & dados numéricos , Custos e Análise de Custo , Craniossinostoses/economia , Craniotomia/economia , Feminino , Humanos , Lactente , Tempo de Internação/economia , Tempo de Internação/estatística & dados numéricos , Masculino , Duração da Cirurgia , Cuidados Pós-Operatórios/economia , Estudos Retrospectivos , Resultado do Tratamento , Procedimentos Desnecessários/economia , Procedimentos Desnecessários/estatística & dados numéricos
3.
J Plast Reconstr Aesthet Surg ; 66(6): 763-9, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23582504

RESUMO

OBJECTIVE: Past studies found insurance status, race, comorbidities and hospital setting influence the likelihood and timing of post-mastectomy breast reconstruction (BR). We evaluated these factors at a public hospital serving a predominantly minority and uninsured population. METHODS: Women who underwent mastectomy and/or BR from 2005 to 2011 were reviewed. The association between patients' characteristics and receipt of BR and timing (immediate BR vs. delayed BR) were analyzed. The 5-year overall BR rate was estimated with the Kaplan-Meier method. RESULTS: The analysis included 387 patients. 130 received BR. 85 (65%) received immediate BR and 25 (19%) underwent microsurgical repair. The total complication rate was 25%. The 5 yr overall BR rate was 43% (95% CI: 36%-51%). Univariate factors positively associated with overall BR included younger age, non-smoker, lower BMI, no comorbidities, no neoadjuvant chemotherapy requirement, lower AJCC stage and negative lymph nodes. Younger age, no comorbidities, neoadjuvant chemotherapy, higher AJCC stage, and positive lymph nodes were positively associated with delayed breast reconstruction compared to immediate BR. Multivariate regression models show patient of younger age (p<0.001), BMI less than 30 (p<0.01), negative lymph nodes (p<0.03) and no neoadjuvant chemotherapy requirement (p<0.01) are more likely to have BR overall: young patients (p<0.02) are more likely to have delayed BR. Race and insurance type were not significantly associated with BR or timing of BR given the patient population. CONCLUSION: At a public hospital, serving a largely uninsured population, post-mastectomy rates of immediate BR and overall BR within 5 yrs are 22% and 43%, respectively. Overall complication rates were low and a substantial fraction of post-mastectomy patients received microsurgical BR. Contrary to previous studies, race and insurance status were not found to be the primary drivers of post-mastectomy reconstruction.


Assuntos
Neoplasias da Mama/cirurgia , Mamoplastia/métodos , Mastectomia , Fatores Etários , Índice de Massa Corporal , Neoplasias da Mama/patologia , Comorbidade , Etnicidade/estatística & dados numéricos , Feminino , Hospitais Públicos , Humanos , Cobertura do Seguro/estatística & dados numéricos , Metástase Linfática , Pessoa de Meia-Idade , Terapia Neoadjuvante , Estadiamento de Neoplasias , Complicações Pós-Operatórias , Valor Preditivo dos Testes , Análise de Regressão , Fumar/epidemiologia , Populações Vulneráveis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA